Five things for pharma marketers to know: Wednesday, August 23, 2017

Share this content:

Photo Credit: Brent Stirton for Novartis/Verbatim Agency

1. Doctors are worried about how much Novartis' experimental CAR-T therapy, a treatment for leukemia, will cost if approved by the FDA. Health officials in the U.K. have said that a $649,000 price tag is justified based on its clinical benefits. (Kaiser Health News)

2. A clinical study that tested the use of digital pillboxes — as a way to improve medication adherence — found that there was no difference in adherence rates, when compared to patients using a standard pillbox. (NPR)

3. India awarded Pfizer a patent for its pneumonia vaccine Prevnar 13, which allows the drugmaker to exclusively market the vaccine in India until 2026. Doctors Without Borders is opposed to the patent. (Reuters)

4. WPP said consumer-goods firms are cutting back on ad spending, notably in North America. Executives at the holding company now predict revenue growth between 0% and 1% in 2017. (WSJ, Ad Age)

5 .Couples in which both partners are physicians reported that the women in those relationships who have with children work less than women who do not have kids, according to a new study. Being a parent does not impact how often male physician partners work. (Reuters)

Share this content:
Scroll down to see the next article